- Home
- MRNA vs TXRH Comparison
MRNA vs TXRH Comparison
Compare MRNA & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- TXRH
- Stock Information
- Founded
- MRNA 2010
- TXRH 1993
- Country
- MRNA United States
- TXRH United States
- Employees
- MRNA N/A
- TXRH N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- TXRH Restaurants
- Sector
- MRNA Health Care
- TXRH Consumer Discretionary
- Exchange
- MRNA Nasdaq
- TXRH Nasdaq
- Market Cap
- MRNA 10.6B
- TXRH 11.4B
- IPO Year
- MRNA 2018
- TXRH 2004
- Fundamental
- Price
- MRNA $26.56
- TXRH $195.21
- Analyst Decision
- MRNA Hold
- TXRH Buy
- Analyst Count
- MRNA 19
- TXRH 21
- Target Price
- MRNA $48.13
- TXRH $191.62
- AVG Volume (30 Days)
- MRNA 14.2M
- TXRH 1.1M
- Earning Date
- MRNA 05-01-2025
- TXRH 05-08-2025
- Dividend Yield
- MRNA N/A
- TXRH 1.39%
- EPS Growth
- MRNA N/A
- TXRH 30.91
- EPS
- MRNA N/A
- TXRH 6.48
- Revenue
- MRNA $3,177,000,000.00
- TXRH $5,499,763,000.00
- Revenue This Year
- MRNA N/A
- TXRH $11.10
- Revenue Next Year
- MRNA $8.98
- TXRH $8.89
- P/E Ratio
- MRNA N/A
- TXRH $30.13
- Revenue Growth
- MRNA N/A
- TXRH 15.09
- 52 Week Low
- MRNA $23.15
- TXRH $148.73
- 52 Week High
- MRNA $158.82
- TXRH $206.04
- Technical
- Relative Strength Index (RSI)
- MRNA 50.60
- TXRH 65.92
- Support Level
- MRNA $25.22
- TXRH $186.52
- Resistance Level
- MRNA $27.15
- TXRH $199.99
- Average True Range (ATR)
- MRNA 1.61
- TXRH 4.13
- MACD
- MRNA 0.26
- TXRH 0.45
- Stochastic Oscillator
- MRNA 47.66
- TXRH 69.00
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.